These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1874006)

  • 1. Medical management of early-stage breast cancer.
    Bookman MA; Goldstein LJ; Scher RM
    Curr Probl Cancer; 1991; 15(4):157-232. PubMed ID: 1874006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The curability of breast cancer and the treatment of advanced disease.
    Guarneri V; Conte PF
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S149-61. PubMed ID: 15107948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus conference. Adjuvant chemotherapy for breast cancer.
    JAMA; 1985 Dec; 254(24):3461-3. PubMed ID: 4068189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of recurrence for advanced breast cancer. Traditional and contemporary pathologic and molecular markers.
    Masood S
    Surg Oncol Clin N Am; 1995 Oct; 4(4):601-32. PubMed ID: 8535901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy of node-negative breast cancer.
    Hall PD; Lesher BA; Hall RK
    Ann Pharmacother; 1995 Mar; 29(3):289-98. PubMed ID: 7606076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New paradigms in adjuvant systemic therapy of breast cancer.
    Thomas E; Hortobagyi GN
    Endocr Relat Cancer; 2003 Mar; 10(1):75-89. PubMed ID: 12653671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy of breast cancer.
    Davidson NE; Abeloff MD
    World J Surg; 1994; 18(1):112-6. PubMed ID: 8197765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of tumor biological prognostic factors in adjuvant therapy of node-negative breast cancer].
    Jänicke F
    Zentralbl Gynakol; 1994; 116(8):449-55. PubMed ID: 7941813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
    Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N
    Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic overview of chemotherapy effects in breast cancer.
    Bergh J; Jönsson PE; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):253-81. PubMed ID: 11441936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant systemic therapy for lymph node-negative breast cancer less than or equal to 1 cm.
    Russell CA
    Curr Womens Health Rep; 2002 Apr; 2(2):134-9. PubMed ID: 12116603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in breast cancer.
    Merkel DE; Osborne CK
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):641-52. PubMed ID: 2558104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature.
    Hanrahan EO; Valero V; Gonzalez-Angulo AM; Hortobagyi GN
    J Clin Oncol; 2006 May; 24(13):2113-22. PubMed ID: 16648513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Swedish Breast Cancer Cooperative Group.
    J Natl Cancer Inst; 1996 Nov; 88(21):1543-9. PubMed ID: 8901852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    CMAJ; 1998 Feb; 158 Suppl 3():S52-64. PubMed ID: 9484279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.